Invertigation of Suspected Infection in Critically Ill Patients

Fassbender K Pargger H Muller W Zimmerli W . Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: diagnostic signs in nosocomial infection. Crit Care Med 1993; 21: 1175–80.

Parnaby RM Eaton SM Shafi MS Bell D . The value of serum C-reactive protein levels as a marker of sepsis in intensive care unit patients. Clin Intensive Care 1994; 5: 106–13.

Povoa P Almeida E Moreira P Fernandes A Mealha R Aragao A Sabino H . C-reactive protein as an indicator of sepsis. Intensive Care Med 1998; 24: 1052–6.

Circiumaru B Baldock G Cohen J . A prospective study of fever in the intensive care unit. Intensive Care Med 1999; 25: 668–73.

Miller PR Munn DD Meredith JW Chang MC . Systemic inflammatory response syndrome in the trauma intensive care unit: who is infected? J Trauma 1999; 47: 1004–8.

Yentis SM Soni N Sheldon J . C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995; 21: 602–5.

Reny JL Vuagnat A Ract C Benoit MO Safar M Fagon JY . Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002; 30: 529–35.

Lobo SM Lobo FR Bota DP Lopes-Ferreira F Soliman HM Melot C Vincent JL . C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123: 2043–9.

Carrol ED Thomson A Hart CA . Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002; 20: 1–9.

Selberg O Hecker H Martin M Klos A Bautsch W Kohl J . Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000; 28: 2793–8.

Claeys R Vinken S Spapen H ver Elst K Decochez K Huyghens L Gorus FK . Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30: 757–62.

Brunkhorst FM Al-Nawas B Krummenauer F Forycki ZF Shah PM . Procalcitonin, C-reactive protein, and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002; 8: 93–100.

Pettila V Hynninen M Takkunen O Kuusela P Valtonen M . Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28: 1220–5.

Luzzani A Polati E Dorizzi R Rungatscher A Pavan R Merlini A . Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737–41.

Suprin E Camus C Gacouin A Le Tulzo Y Lavoue S Feuillu A Thomas R . Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med 2000; 26: 1232–8.

Ugarte H Silva E Mercan D De Mendonca A Vincent JL . Procalcitonin used a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498–504.

Christ-Crain M Jaccard-Stolz D Bingisser R Gencay MM Huber PR Tamm M Muller B . Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600–7.

Edgeworth JD Treacher DF Eykyn SJ . A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999; 27: 1421–8.

Blot F Nitenberg G Chachaty E Raynard B Germann N Antoun S Laplanche A Brun-Buisson C Tancrede C . Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354: 1071–7.

Chastre J Fagon J-Y . Ventilator-associated pneumonia. Am JRespir Crit Care Med 2002; 165: 867–903.

Heyland D Ewig S Torres A . Pro/con clinical debate: the use of a protected specimen brush in the diagnosis of ventilator-associated pneumonia. Crit Care 2002; 6: 117–20.

Pugin J . Clinical signs and score for the diagnosis of ventilator-associated pneumonia. Minerva Anestesiol 2002; 68: 261–5.

British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56, Suppl. 4: S1–64.

Leone M Albanese J Garnier F Sapin C Barrau K Bimar M-C Martin C . Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med 2003; 29: 1077–80.

Tissot E Woronoff-Lemsi M-C Cornette C Plesiat P Jacquet M Capellier G . Cost-effectiveness of urinary dipsticks to screen asymptomatic catheter-associated urinary infections in an intensive care unit. Intensive Care Med 2001; 27: 1842–7.

Begg N Cartwright KA Cohen J Kaczmarski EB Innes JA Leen CL . Consensus statement on diagnosis, investigation, treatment, and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect 1999; 39: 1–15.

Klapper PE Cleator GM . European guidelines for diagnosis and management of patients with suspected Herpes simplex encephalitis. Clin Microbiol Infect 1998; 4: 178–80.

Horstkotte D Follath F Gutschik E Lengyel M Oto Pavie A Soler-Soler J Thiene G von Graevenitz A Guuidelines on prevention, diagnosis, and treatment of infective endocarditis – executive summary. The Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25: 267–76.

Rohner P Pittet D Pepey B Nije-Kinge T Auckenthaler R . Etiological agents of infectious diarrhea: implications for request for microbiological culture. J Clin Microbiol 1997; 35: 1427–32.

Bauer TM Lalvani A Fehrenbach J Steffen I Aponte JJ Segovia R Vila J Philippczik G Steinbruckner G Frei R Bowler I Kist M . Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 2001; 285: 313–9.